Search for: "Merck Co., Inc."
Results 421 - 440
of 664
Sorted by Relevance
|
Sort by Date
9 Dec 2009, 3:59 pm
Amgen Inc. [read post]
2 Jun 2011, 12:46 pm
Searle & Co., 748 F. [read post]
12 Dec 2008, 11:45 pm
Merck & Co., Inc., Rahway, N.J. e. [read post]
15 Apr 2024, 10:40 am
Merck & Co., 888 F.3d 1231 (Fed. [read post]
27 Aug 2012, 6:48 am
On Friday a cert. petition was filed in Merck & Co., Inc., v. [read post]
20 Feb 2007, 7:00 am
The decision gives new ammunition to frequent targets of product-liability suits, including Merck & Co., which faces as many as 40,000 claims over its withdrawn Vioxx painkiller, and Ford Motor Co., whose Explorer sport-utility vehicle has spawned hundreds of claims over rollover accidents. [read post]
30 Dec 2011, 6:53 am
Merck & Co., Inc. v. [read post]
5 Aug 2007, 7:23 pm
Totura & Co., Inc. v. [read post]
18 Jan 2011, 3:10 am
See, e.g., Merck & Co., Inc. v. [read post]
30 Sep 2014, 9:36 pm
., Inc., No. 2014-1140 (Fed. [read post]
27 May 2010, 3:20 am
(Patent Docs) US: Genetic Technologies’ patent in suit against Monsanto and Pioneer Hi-Bred upheld on re-examination (Patent Docs) Products Angiomax (Bivalirudin) - US: Court orders and PTO grants second interim PTE for Angiomax (FDA Law Blog) Cancidas (Caspofungin) – US: Patent infringement complaint following Para IV certification: Merck & Co, Inc. et al. v. [read post]
30 Apr 2010, 11:52 am
And at Merck & Co., Inc. [read post]
30 Apr 2010, 11:52 am
And at Merck & Co., Inc. [read post]
30 Aug 2019, 6:31 am
Interestingly, Canadian courts used to follow the British approach but, in its recent decision in Merck & Co. v. [read post]
17 Oct 2008, 1:32 pm
Proposed EU information laws on prescription drugs (IPmed) Iceland: Supplementary Protection Certificates (SPCs) in Iceland (The SPC blog) India: Roche implements 'mass serialisation' anti-counterfeiting technology (Spicy IP) Indonesia: Patent application on oil palm hybrids (navigating the patent maze) United States: New PMCA research: State legislative proposals restricting access to generic medicines would increase cost $29 billion over 10 years (GenericsWeb) US: Pharmaceutical… [read post]
24 Oct 2012, 11:00 am
” [3] When the terminal disclaimer was filed on July 2, 2010, the application that issued as the ‘176 patent and the ‘789 patent were also owned by Email Link and Online News Link. [4] Merck & Co., Inc. v. [read post]
19 Dec 2013, 4:56 pm
(Enlarged Board of Appeal in G2/98).Priority can be lost by:narrowing down the disclosure from the priority document in a manner which the invention could not be derived directly and unambiguously from it (Pharmacia Corp v Merck & Co Inc [2002] RPC 41); orwidening or generalizing from the priority disclosure (Beloit Technologies Inc and another v Valmet Paper Machinery Inc and another [1995] RPC 7005 and Unilin)The story continues in Part II. [read post]
8 Apr 2016, 12:42 pm
Under Merck & Co., Inc. v. [read post]
17 Sep 2007, 2:00 pm
Teleflex Inc., 127 S. [read post]
29 Dec 2008, 9:00 pm
Merck & Co., 948 A.2d 587 (N.J. 2008). [read post]
